A phase II study of adjuvant gemcitabine plus docetaxel followed by concurrent chemoradation in resected pancreaticobiliary carcinoma

Publisher： John Wiley & Sons Inc

E-ISSN： 1477-2574|17|7|587-593

ISSN： 1365-182x

Source： HPB, Vol.17, Iss.7, 2015-07, pp. : 587-593

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phase II Study of Gemcitabine plus Docetaxel in Advanced Pancreatic Cancer: A Hoosier Oncology Group Study

By  

Oncology, Vol. 65, Iss. 3, 2003-12 ,pp. : 218-223

Karger

Access to resources Recommend Favorite

Phase II Study of Gemcitabine in Combination with Docetaxel in Patients with Advanced Pancreatic Carcinoma (E1298)

By  

Oncology, Vol. 66, Iss. 4, 2004-06 ,pp. : 303-309

Karger

Access to resources Recommend Favorite

Phase II Study of First-Line Sequential Chemotherapy with Gemcitabine-Carboplatin Followed by Docetaxel in Patients with Advanced Non-Small Cell Lung Cancer

By  

Oncology, Vol. 68, Iss. 4-6, 2005-08 ,pp. : 382-390

Karger

Access to resources Recommend Favorite

Phase II Feasibility Study of Adjuvant S-1 plus Docetaxel for Stage III Gastric Cancer Patients after Curative D2 Gastrectomy

By  

Oncology, Vol. 80, Iss. 5-6, 2011-07 ,pp. : 296-300

Karger

Access to resources Recommend Favorite

Phase II study of celecoxib with docetaxel chemoradiotherapy followed by consolidation chemotherapy docetaxel plus cisplatin with maintenance celecoxib in inoperable stage III nonsmall cell lung cancer

By  

ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, Vol. 14, Iss. 1, 2018-02 ,pp. : 91-100

John Wiley & Sons Inc

Access to resources Recommend Favorite